Processes and intermediates for preparing retroviral protease inhibitors
CA 2731273 C · Owner: Abbvie Inc. · Inventors: Chemburkar, Sanjay R.; Spiwek, Harry O.; Patel, Ketan M.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The instant invention provides processes and intermediates employed in the synthesis of ((2S,3S,5S)-2-(2,6-dimethylphenoxyacetyl)-amino-3-hydroxy-5-(2S-(1- tetrahydropyrimid- 2-onyl)-3-methyl-butanoyl)amino-1,6-diphenylhexane and analogs thereof.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 29, 2001 and granted October 15, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 29, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 29, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.